Jeyaraman Jeyakanthan

Alagappa University

H指数:31

被引数:3,748

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional Annotation Identifies 3-Oxoacyl Synthase III as a Druggable Target in Nocardia asteroides FDAARGOS1485: A Multi-Tier Structure-Guided Computational Discovery of Marine-Derived Therapeutic Leads

功能注释鉴定3-氧酰基合成酶III为诺卡氏菌FDAARGOS1485中可成药的靶点：基于海洋来源治疗先导物的多层级结构导向计算发现

Applied Biochemistry and Biotechnology

IF3.3

2026-09-160

PRE

Investigating Marine Natural Products as Potential Antivirals of Mpox Virus Replication by Targeting Thymidylate Kinase

ACS Omega

IF4.3

2026-01-270

Biogenic Synthesis of Blue Luminescent Carbon Quantum Dots From Gymnema sylvestre for Anticancer Studies

从 Gymnema sylvestre 中生物合成蓝色发光碳量子点用于抗癌研究

ChemistrySelect

IF2

2026-01-030

PRE

Rational design and structural Bioinformatics-Driven discovery of tetrapeptide inhibitors for LIMK-Targeted cancer therapy

理性设计及结构生物信息学驱动的靶向LIMK癌症疗法的四肽抑制剂发现

Medical Oncology

IF3.5

2025-12-260

PRE

Binding modes and interaction mechanism of bisphenol A and its analogs in constitutive androstane receptor

结合模式及二酚A与其类似物在组成性类固醇受体中的相互作用机制

Scientific Reports

IF3.9

2025-12-120

Targeting Catalytic Residues of TKTL1: A Multi-Approach Study With Thiamine Analogs Combining QSAR, Pharmacophore Modeling, DFT, and Molecular Dynamics

靶向TKTL1催化残基：一项结合QSAR、药效团建模、DFT和分子动力学的多种方法研究，使用硫胺素类似物

CHEMISTRYSELECT

IF2

2025-12-030

PRE

Structure-Guided Design of Isoform-Selective LIMK1 Inhibitors: A Peptidomimetic Screening Approach with Molecular Dynamics and Quantum Mechanical Characterization

基于结构的异构体选择性LIMK1抑制剂设计：结合分子动力学和量子力学表征的肽模拟筛选方法

Journal of Computational Biophysics and Chemistry

IF2.3

2025-12-010

PRE

Computational Identification of FDA-Approved Drugs as Potential BMX Inhibitors: An Integrated Virtual Screening, Pharmacokinetics and Molecular Dynamics Study

CHEMISTRYSELECT

IF2

2025-10-301

PRE

Unraveling the Bifunctional HisIE Enzyme in Acinetobacter baumannii JJAB01: A Novel Therapeutic Target for Combating Antimicrobial Resistance

解析鲍曼不动杆菌JJAB01中的双功能HisIE酶：一种新型抗耐药性治疗的靶点

Apmis

IF2.6

2025-10-010

PRE

Designing novel potent oxindole derivatives as VEGFR2 inhibitors for cancer therapy: Computational insights from molecular docking, drug-likeness, DFT, and structural dynamics studies

设计新型强效恶唑烷酮衍生物作为VEGFR2抑制剂用于癌症治疗：分子对接、成药性、DFT和结构动力学研究的计算见解

JOURNAL OF MOLECULAR GRAPHICS & MODELLING

IF3

2025-07-010

PRE

Exploring phytochemicals and marine natural products as alternative therapeutic agents targeting phosphotransacetylase (PTA) in Mycobacterium tuberculosis: An underexplored drug target

探索植物化学物质和海洋天然产物作为靶向结核分枝杆菌中磷酸转移酶（PTA）的替代治疗剂：一个尚未充分开发的药物靶点

JOURNAL OF MOLECULAR GRAPHICS & MODELLING

IF3

2025-07-010

PRE

A promising strategy to disrupt Plasmodium falciparum metabolic resilience by targeting G6PD: Virtual screening for potential inhibitors against malaria

靶向G6PD以破坏恶性疟原虫代谢韧性的可行策略：针对疟疾的潜在抑制剂虚拟筛选

computational chemistry

IF3.1

2025-06-020

PRE

Computational design and structural insights into quinazoline-based lead molecules for targeting PARP10 in cancer therapy

基于喹唑啉骨架的先导分子靶向PARP10的癌症疗法的计算设计与结构洞察

JOURNAL OF MOLECULAR GRAPHICS & MODELLING

IF3

2025-06-010

PRE

Exploring Marine natural products as potential Quorum sensing inhibitors by targeting the PqsR in Pseudomonas aeruginosa: Virtual screening assisted structural dynamics study

探索靶向铜绿假单胞菌(Pseudomonas aeruginosa)中PqsR的海洋天然产物作为潜在群体感应抑制剂的虚拟筛选辅助结构动力学研究

PLOS ONE

IF2.6

2025-03-280

Whole genome sequencing characterization and comparative genome analysis of Acinetobacter baumannii JJAB01: A comprehensive insights on antimicrobial resistance and virulence genotype

鲍曼不动杆菌JJAB01全基因组测序特征和比较基因组分析: 耐药性和毒力基因型的综合认识

MICROBIAL PATHOGENESIS

IF3.5

2025-02-010

PRE

Spatio-temporal localization of P21-activated kinase in endometrial cancer

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

IF2.7

2024-11-060

PRE

Harnessing marine natural products to inhibit PAD4 triple mutant: A structure-based virtual screening approach for rheumatoid arthritis therapy

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

2024-11-012

PRE

Computational discovery of AKT serine/threonine kinase 1 inhibitors through shape screening for rheumatoid arthritis intervention

MOLECULAR DIVERSITY

IF3.8

2024-07-060

PRE

Unveiling the intricacies of allosteric regulation in aspartate kinase from the Wolbachia endosymbiont of Brugia Malayi : Mechanistic and

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-05-011

PRE

In silico approaches for the identification of potential allergens among hypothetical proteins from Alternaria alternata and its functional annotation

SCIENTIFIC REPORTS

IF3.9

2024-03-202

OAAI

Jeyaraman Jeyakanthan

个人简介

教育背景

工作经历

荣誉奖项

研究方向